PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
55 hedge funds and large institutions have $194M invested in POINT Biopharma Global Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
55
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.1M | |
| 2 | +$2.51M | |
| 3 | +$2.35M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$2.12M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.07M |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$2.97M | |
| 3 | -$1.27M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$821K |
| 5 |
PA
Perceptive Advisors
New York
|
-$274K |